Shearman & Sterling advised Quest Diagnostics Incorporated in connection with its tender offer for up to $200 million of its outstanding 6.950% Senior Notes due 2037 and 5.750% Senior Notes due 2040. J.P. Morgan Securities LLC acted as the dealer manager.
Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.
The following Shearman & Sterling attorneys advised Quest Diagnostics Incorporated in this transaction: of counsel Robert C. Treuhold (New York-Capital Markets) partner Stephen Giove (New York-Capital Markets) and associates Minsoo Kwon (New York-Capital Markets) and Daniel Yao (New York-Corporate). Other key members of the team included partner Douglas R. McFadyen (New York-Tax) and associate Adam Sternberg (New York-Tax).